Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with new prices for the current list of drugs expected to take effect from 1 ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.

NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle ...

The list has been announced by the Centers for Medicare & Medicaid Services (CMS) shortly after the reductions agreed for the ...

Social Security and Medicare are by far the biggest contributors to our national debt. The federal government spent $1.6 ...